KFF Health Tracking Poll: Public Views on Fraud in Government Health Programs

• by Audrey Kearney, Isabelle Valdes, Lunna Lopes, Mardet Mulugeta, Liz Hamel

• July 16, 2026

Charlson comorbidity Index for descriptive risk stratification of long-term All-cause mortality in elderly patients with acute myocardial infarction: a retrospective cohort study

• by Fengxiang Han, Pengyuan Zhao, Yukun Xia, Xiaoxu Liu, Liting Yin, Shuxia Liu, Sheng Guo

• July 17, 2026

Protein lactylation in myocardial ischemia-reperfusion injury: mechanisms and therapeutic potential

• by Hang Zhan, Die Li, Jiayao He, Yuzhuang Hu, Wei Jiang, Jiayu Zhang, Wei Chen, Weize Xu

• July 16, 2026

Oral Aleniglipron Reduced Weight at 36 Weeks

In a phase 2b trial, the highest dose produced an estimated 12% mean weight reduction vs 1% with placebo, although gastrointestinal adverse events were common.

• by Kathryn Wighton

• July 16, 2026

• 6 min